Kimberly-Clark Corporation (FRA:KMY)

Blueprint Medicines Revenue

Kimberly-Clark had revenue of $4.84B USD in the quarter ending March 31, 2025, a decrease of -6.00%. This brings the company's revenue in the last twelve months to $19.75B, down -3.12% year-over-year. In the year 2024, Kimberly-Clark had annual revenue of $20.06B, down -1.83%.

• Revenue (ttm): $19.75B
• Revenue Growth: -3.12%
• P/S Ratio: 2.15
• Revenue / Employee: $519.71K
• Employees: 38,000
• Market Cap: 36.15B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	20.06B	-373.00M	-1.83%
Dec 31, 2023	20.43B	256.00M	1.27%
Dec 31, 2022	20.18B	735.00M	3.78%
Dec 31, 2021	19.44B	300.00M	1.57%
Dec 31, 2020	19.14B	690.00M	3.74%